For the quarter ending 2025-09-30, BOLD has $168,721K in assets. $58,552K in debts. $14,980K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 14,980 | 14,697 | ||
| Short-term investments | 102,590 | 112,451 | ||
| Prepaid expenses and other current assets | 2,586 | 2,542 | ||
| Total current assets | 120,156 | 129,690 | ||
| Total property and equipment | 8,150 | - | ||
| Less accumulated depreciation and amortization | 4,651 | - | ||
| Property and equipment, net | 3,499 | 3,794 | ||
| Right-of-use asset, net | 44,480 | 45,365 | ||
| Restricted cash | 560 | 560 | ||
| Other assets | 26 | 44 | ||
| Total assets | 168,721 | 179,453 | ||
| Accounts payable and accrued liabilities | 6,773 | 5,855 | ||
| Accrued compensation | 2,020 | 1,397 | ||
| Lease liabilities, current portion | 3,052 | 1,961 | ||
| Total current liabilities | 11,845 | 9,213 | ||
| Lease liabilities, non-current | 46,707 | 47,549 | ||
| Total liabilities | 58,552 | 56,762 | ||
| Common stock, 0.0001 par value 700,000 shares authorized at september 30, 2025 and december 31, 2024 22,386 and 22,300 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 2 | 2 | ||
| Additional paid-in-capital | 356,901 | 355,598 | ||
| Accumulated other comprehensive income | 50 | -4 | ||
| Accumulated deficit | -246,784 | -232,905 | ||
| Total stockholders' equity | 110,169 | 122,691 | ||
| Total liabilities and stockholders' equity | 168,721 | 179,453 | ||
Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc. (BOLD)